Argatra 100mg/ml, Konzentrat zur Herstellung einer Infusionslösung

7680628610015 CH-62861 Konzentrat
Argatra 100mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Argatra 100mg/ml, Konzentrat zur Herstellung einer Infusionslösung
Argatra 100mg/ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1 x 2.5 ml
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
10/03/2025
Summary of Product Characteristics
Français
10/03/2025
Summary of Product Characteristics
Italien
10/03/2025

Detailed composition

Substance Quantity Type Category
argatrobanum monohydricum
100.0 MG Substance Wirkstoff (Principe actif)
argatrobanum
96.5 MG Substance WIIS
sorbitolum
300.0 MG Substance HBESI
ethanolum anhydricum
400.0 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
62861
Drug name
Argatra, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
B01AE03
Authorization status
Z
Dispensing category
B
First authorization
30/12/2014
Authorization expiration date
31/12/9999
IT Number
06.03.0.
Domain
Human medicine
Field of application
Antikoagulation bei erwachsenen Patienten mit HIT-II

Package details

Description (FR)
ARGATRA 100 mg/ml conc perf flac perf 1 pce
Description (DE)
ARGATRA 100 mg/ml Konz Inf Durchstf 1 Stk
Market launch
30/12/2014
Narcotic (BTM)
No

Other package sizes (1)

None
6 x 2.5 ml DUR
GTIN: None
Not in V1
Buy us a coffee Explore the data